Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1984 1
1998 1
2005 2
2015 2
2016 1
2021 2
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis.
Simpson EL, Bieber T, Guttman-Yassky E, Beck LA, Blauvelt A, Cork MJ, Silverberg JI, Deleuran M, Kataoka Y, Lacour JP, Kingo K, Worm M, Poulin Y, Wollenberg A, Soo Y, Graham NM, Pirozzi G, Akinlade B, Staudinger H, Mastey V, Eckert L, Gadkari A, Stahl N, Yancopoulos GD, Ardeleanu M; SOLO 1 and SOLO 2 Investigators. Simpson EL, et al. N Engl J Med. 2016 Dec 15;375(24):2335-2348. doi: 10.1056/NEJMoa1610020. Epub 2016 Sep 30. N Engl J Med. 2016. PMID: 27690741 Free article. Clinical Trial.
Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis.
Bieber T, Simpson EL, Silverberg JI, Thaçi D, Paul C, Pink AE, Kataoka Y, Chu CY, DiBonaventura M, Rojo R, Antinew J, Ionita I, Sinclair R, Forman S, Zdybski J, Biswas P, Malhotra B, Zhang F, Valdez H; JADE COMPARE Investigators. Bieber T, et al. N Engl J Med. 2021 Mar 25;384(12):1101-1112. doi: 10.1056/NEJMoa2019380. N Engl J Med. 2021. PMID: 33761207 Clinical Trial.
Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials.
Griffiths CE, Reich K, Lebwohl M, van de Kerkhof P, Paul C, Menter A, Cameron GS, Erickson J, Zhang L, Secrest RJ, Ball S, Braun DK, Osuntokun OO, Heffernan MP, Nickoloff BJ, Papp K; UNCOVER-2 and UNCOVER-3 investigators. Griffiths CE, et al. Lancet. 2015 Aug 8;386(9993):541-51. doi: 10.1016/S0140-6736(15)60125-8. Epub 2015 Jun 10. Lancet. 2015. PMID: 26072109 Clinical Trial.
Phase 3 Trials of Tirbanibulin Ointment for Actinic Keratosis.
Blauvelt A, Kempers S, Lain E, Schlesinger T, Tyring S, Forman S, Ablon G, Martin G, Wang H, Cutler DL, Fang J, Kwan MR; Phase 3 Tirbanibulin for Actinic Keratosis Group. Blauvelt A, et al. N Engl J Med. 2021 Feb 11;384(6):512-520. doi: 10.1056/NEJMoa2024040. N Engl J Med. 2021. PMID: 33567191 Clinical Trial.
Darier's disease: a partially immunodeficient state.
Jegasothy BV, Humeniuk JM. Jegasothy BV, et al. Among authors: humeniuk jm. J Invest Dermatol. 1981 Feb;76(2):129-32. doi: 10.1111/1523-1747.ep12525466. J Invest Dermatol. 1981. PMID: 7007519 Free article.
Probable vancomycin-associated toxic epidermal necrolysis.
Craycraft ME, Arunakul VL, Humeniuk JM. Craycraft ME, et al. Among authors: humeniuk jm. Pharmacotherapy. 2005 Feb;25(2):308-12. doi: 10.1592/phco.25.2.308.56953. Pharmacotherapy. 2005. PMID: 15767246
Bullous pemphigoid of the vulva: a case report.
Stage AH, Humeniuk JM, Easley WK. Stage AH, et al. Among authors: humeniuk jm. Am J Obstet Gynecol. 1984 Sep 15;150(2):169-70. doi: 10.1016/s0002-9378(84)80011-3. Am J Obstet Gynecol. 1984. PMID: 6383047 No abstract available.
Ketoconazole 2% shampoo in the treatment of tinea versicolor: a multicenter, randomized, double-blind, placebo-controlled trial.
Lange DS, Richards HM, Guarnieri J, Humeniuk JM, Savin RC, Reyes BA, Hickman J, Pariser DM, Pariser RJ, Sherertz EF, Grossman RM, Gisoldi EM, Klausner MA. Lange DS, et al. Among authors: humeniuk jm. J Am Acad Dermatol. 1998 Dec;39(6):944-50. doi: 10.1016/s0190-9622(98)70267-1. J Am Acad Dermatol. 1998. PMID: 9843006 Clinical Trial.
Long-term efficacy and safety of tretinoin emollient cream 0.05% in the treatment of photodamaged facial skin: a two-year, randomized, placebo-controlled trial.
Kang S, Bergfeld W, Gottlieb AB, Hickman J, Humeniuk J, Kempers S, Lebwohl M, Lowe N, McMichael A, Milbauer J, Phillips T, Powers J, Rodriguez D, Savin R, Shavin J, Sherer D, Silvis N, Weinstein R, Weiss J, Hammerberg C, Fisher GJ, Nighland M, Grossman R, Nyirady J. Kang S, et al. Among authors: humeniuk j. Am J Clin Dermatol. 2005;6(4):245-53. doi: 10.2165/00128071-200506040-00005. Am J Clin Dermatol. 2005. PMID: 16060712 Clinical Trial.